David Tapolczay

David Tapolczay

Vorstandsvorsitzender bei CONDUIT PHARMACEUTICALS INC.

Vermögen: 6 Mio $ am 30.04.2024

64 Jahre
Commercial Services
Health Technology
Consumer Services

Profil

David Joszef Tapolczay founded Sigma Entity One Ltd.
in 2003, where he worked as Chairman & Chief Executive Officer, Nuformix Technologies Ltd.
in 2007, where he worked as Non-Executive Chairman from 2007 to 2020, and Nuformix Plc in 2008, where he worked as Non-Executive Chairman from 2008 to 2020.
Dr. Tapolczay also currently works at Conduit Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2023, Medeor Old Ltd., as Director, Medeor LLP, as Director, and Medeor Pharma Ltd., as Director.
Dr. Tapolczay also formerly worked at The Medical Research Council, as Chief Executive Officer, Lifearc, as Chief Executive Officer from 2008 to 2018, Stylacats Ltd., as Chief Executive Officer, Intelligent OMICS Ltd., as Non-Executive Chairman, Bicycle Therapeutics Plc, as Director, Nanoform Cardiovascular Therapeutics Ltd., as Director, Zeneca Agrochemicals, as Manager in 2013, Cambridge Discovery Chemistry, as Vice President-Research & Development, Glaxo Smithkline Plc, as Senior Manager-Chemical Development, GSK Pharmaceutical Trading SA, as VP-Technology Development from 2005 to 2007, Millenium Group Ltd., as Senior Vice President-Pharmaceutical Sciences, Sigma-Aldrich Co. Ltd., as Chief Scientific Officer, and GSK Group Ltd., as Vice President-Technology Development.
Dr. Tapolczay received his undergraduate degree and doctorate degree from Southampton Business School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.05.2024 2 003 324 ( 2,71% ) 6 Mio $ 30.04.2024

Aktive Positionen von David Tapolczay

UnternehmenPositionBeginn
CONDUIT PHARMACEUTICALS INC. Vorstandsvorsitzender 22.09.2023
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Alle aktiven Positionen von David Tapolczay

Ehemalige bekannte Positionen von David Tapolczay

UnternehmenPositionEnde
Gründer 05.02.2020
NUFORMIX PLC Gründer 05.02.2020
Vorstandsvorsitzender 01.12.2018
Technik-/Wissenschafts-/F&E-Leiter 01.04.2007
Glaxo Smithkline Plc /Clinical Pharmacology Unit/ Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von David Tapolczay im Detail an

Ausbildung von David Tapolczay

Southampton Business School Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David Tapolczay im Detail an

Beziehungen

25

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
BICYCLE THERAPEUTICS PLC

Health Technology

NUFORMIX PLC

Health Technology

CONDUIT PHARMACEUTICALS INC.

Health Technology

Private Unternehmen17

Commercial Services

Zeneca Agrochemicals

Commercial Services

Glaxo Smithkline Plc /Clinical Pharmacology Unit/

Commercial Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

GSK Group Ltd.

Health Technology

Health Technology

Stylacats Ltd.

Commercial Services

Commercial Services

Nanoform Cardiovascular Therapeutics Ltd.

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. David Tapolczay